Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL GENETIC TESTING MARKET FORECAST 2022-2030

GLOBAL GENETIC TESTING MARKET FORECAST 2022-2030

The global genetic testing market is expected to reach $27.81 billion by 2030, growing at a CAGR of 10.25% during the forecast period, 2022-2030. The base year considered for the study is 2021, and the estimated period is between 2022 and 2030. The market study has also analyzed the impact of COVID-19 on the genetic testing market qualitatively as well as quantitatively.

GLOBAL GENETIC TESTING MARKET FORECAST 2022-2030

Global Genetic Testing Market by Type (Prenatal and Newborn Testing, Diagnostic Testing, Predictive & Pre symptomatic Testing, Carrier Testing, Pharmacogenomic Testing, Other Types) Market by Technology (Molecular Testing, Cytogenetic Testing, Biochemical Testing) Market by Application (Genetic Disease Diagnosis, Cancer Diagnosis, Cardiovascular Disease Diagnosis, Other Applications) Market by Disease (Cancer, Cystic Fibrosis, Huntington’s Disease, Sickle Cell Anaemia, Duchenne Muscular Dystrophy, Alzheimer’s Disease, Rare Diseases, Thalassemia, Other Diseases) by Geography

Request free sample

The global genetic testing market is expected to reach $27.81 billion by 2030, growing at a CAGR of 10.25% during the forecast period, 2022-2030. The base year considered for the study is 2021, and the estimated period is between 2022 and 2030. The market study has also analyzed the impact of COVID-19 on the genetic testing market qualitatively as well as quantitatively.

To learn more about this report, request a free sample copy

Genetic testing is a medical and diagnostic test that looks for changes in DNA, chromosomes, genes, or proteins. Medical professionals analyze the results of the samples to identify any defects and abnormalities in the DNA sequencing. This data can be used to determine whether the person is at risk of developing certain diseases or disorders.

Genetic Testing Market

Read our latest blog on the Genetic Testing Market

Prenatal testing, newborn screening, and diagnostic testing equipment are the main types of genetic testing. Furthermore, genetic testing may include technology such as molecular testing, cytogenetic testing, biochemical testing, etc.

Key enablers of the global genetic testing market growth are:

  • Growth in prenatal testing
    • Prenatal testing is a test to detect some types of abnormalities in a baby’s genes. Pollution has significantly increased across the globe, given the rising industrial activities, which have severe impacts on human health, contributing to diseases and pre-birth defects.
    • Parents fear that their children may develop genetic disorders. In some genetic diseases, proper surveillance, as well as early action, can save the individual. For example, the early detection of hereditary cancer. Since people share DNA with their family members, if a person is found to have a genetic change, their family members may have the same change. Such co-relation of family relationships and diseases are enabling wide scope of genetic testing.
  • Advancement in biotechnology
  • Rise in Direct-to-Consumer genetic testing

Key growth restraining factors are:

  • Expensive cost of treatment
    • The research and input costs of genetic tests are high. Hence, testing is expensive. In the United States, the genetic testing cost can range between $100 and $2,000, depending upon the disease and type of the test.
    • In addition, developing countries face the problem of the high costs of genetic testing. For instance, genetic tests start from $100 in India, with some tests costing $1000, thus making it an unaffordable option.
  • Government regulations and legislations

Genetic Testing Market | Top Trends

  • North America is poised to remain the dominating market for genetic testing. North America is dominated by major Fortune 500 medical companies and big pharma companies. The technological developments and biotechnology advancements in North America provide a positive growth trajectory for the companies. Besides, North America enjoys high per capita income and purchasing power.
  • The Asia-Pacific provides a lucrative market for genetic testing. It consists of developed, emerging markets that are conducive to the growth of diagnostic testing. The potential market growth is high and untapped with regard to prenatal testing. Asia-Pacific is expected to be the fastest-growing market and is set to reach a valuation of $6.66 billion, growing at a CAGR of 10.49%.
  • Occurrences of cancers around the world have increased by a huge percentage. Cancer is a major cause of death across the globe, responsible for 10 million deaths in 2020, or approximately one in six deaths. Due to the complexity of cancer treatment, it is important for the early detection of genetic mutations.

Market Segmentation Analysis – Type, Technology, Application, and Disease

Market by Type:

  • Pharmacogenomic Testing
    • Pharmacogenomic testing is anticipated to be the fastest-growing type in the market, with an anticipated CAGR of 11.23%. Pharmacogenomic testing helps determine the dosage of medicine to a patient based on his genetic factors.
    • Also, this testing will help to notify the medical professional if the patient has an allergy or history of allergic reaction to a certain drug.
    • The companies offering pharmacogenomic testing include Abbott Laboratories, Illumnia Inc, Roche Diagnostics, etc.
  • Prenatal and newborn testing
  • Diagnostic Testing
  • Predictive & Presymptomatic Testing
  • Carrier Testing
  • Other Types

Market by Technology:

  • Molecular Testing
    • Molecular testing is the largest genetic testing technology in terms of market size.
    • Molecular tests augment particles of viral RNA so that viruses can be spotted early using a specific test.
    • Augmentation of viral genomic material enables small samples of the virus to be detected.
    • Qiagen, Roche Diagnostics, Abbott Laboratories are some companies with expertise in molecular technology.
  • Biochemical Testing
  • Cytogenetic Testing

Market by Application:

  • Genetic Disease Diagnosis
  • Cancer Diagnosis
  • Cardiovascular Diseases Diagnosis

Market by Disease:

  • Cancer
  • Cystic Fibrosis
  • Huntington’s Disease
  • Sickle Cell Anaemia
  • Duchenne Muscular Dystrophy
  • Alzheimer’s Disease
  • Rare Diseases
  • Thalassemia
  • Other Diseases

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Spain, Italy, Russia, Nordic Countries, and Rest of Europe
    • Europe has a great healthcare system, and government subsidies benefit the healthcare industry. Germany’s healthcare spending had increased since 2002 when it was 228.7 billion euros.
    • Also, Europe is home to major biotechnology and medical companies such as Roche Diagnostics, Eurofins Scientific, Decode Genetics, and Qiagen. The recent COVID-19 vaccines were developed in European countries.
    • Italy has 560,000 births per year. In 2020, Italy’s healthcare budget was 123 billion euros. Cytogenetic prenatal diagnostic in public services is allowed for mothers over 35 years of age and above, parents with the previous child suffering from chromosome conditions, parents with a constitutional chromosomal abnormality, and for ultrasound detecting abnormal readings.
  • Asia Pacific: China, Japan, India, South Korea, Indonesia, Taiwan, Singapore, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, Middle East & Africa

The major players in the global genetic testing market are:

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • Illumina Inc
  • 23andMe
  • Others

Key strategies adopted by some of these companies:

In Feb 2021, 23andMe decided to merge with VG Acquisition Corp, an acquisition company founded by billionaire Richard Branson and plans to go public. Furthermore, Celsee Inc, a single-cell analysis solutions provider, was acquired by Bio-Rad Acquires in April 2020.

In Sept 2021, Illumina expanded in Latin America. Also, in June 2021, Qiagen Partnered with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions.

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Type, Technology, Application, and Disease
Geographies Analyzed North America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

Abbott Laboratories, Bio-Rad Laboratories, Myriad Genetics, Illumina, Inc, PerkinElmer, Qiagen, Quest Diagnostics, Eurofins Scientific SE, 23andMe Holding Co, Luminex Corporation, Roche Holding AG, ElitechGroup, deCODE genetics, CSL Limited, BGI Group

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • ADVANCEMENTS IN BIOTECHNOLOGY
      • GROWTH IN PRENATAL TESTING
      • RISE IN DIRECT-TO-CONSUMER GENETIC TESTING
      • GENETIC TESTING HELPS IN DETERMINING MEDICATION DOSAGE
    • KEY RESTRAINTS
      • EXPENSIVE COST OF TREATMENT
      • GOVERNMENT REGULATION AND LEGISLATION
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON GENETIC TESTING MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • REGULATORY FRAMEWORK
  2. MARKET BY TYPE
    • PRENATAL AND NEWBORN TESTING
    • DIAGNOSTIC TESTING
    • PREDICTIVE & PRESYMPTOMATIC TESTING
    • CARRIER TESTING
    • PHARMACOGENOMIC TESTING
    • OTHER TYPES
  3. MARKET BY TECHNOLOGY
    • MOLECULAR TESTING
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
  4. MARKET BY APPLICATION
    • GENETIC DISEASE DIAGNOSIS
    • CANCER DIAGNOSIS
    • CARDIOVASCULAR DISEASE DIAGNOSIS
    • OTHER APPLICATIONS
  5. MARKET BY DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • HUNTINGTON’S DISEASE
    • SICKLE CELL ANAEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • ALZHEIMER’S DISEASE
    • RARE DISEASES
    • THALASSEMIA
    • OTHER DISEASES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • SPAIN
        • ITALY
        • RUSSIA
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATE
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • AUSTRALIA & NEW ZEALAND
        • SINGAPORE
        • TAIWAN
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • 23&ME INC
      • ABBOTT LABORATORIES
      • BGI GROUP
      • BIO-RAD LABORATORIES
      • CSL LIMITED
      • DECODE GENETICS
      • ELITECH GROUP
      • EUROFINS SCIENTIFIC
      • ILLUMINA INC
      • LUMINEX CORPORATION
      • MYRIAD GENETICS INC
      • PERKINELMER INC
      • QIAGEN
      • QUEST DIAGNOSTICS INC
      • ROCHE DIAGNOSTICS INC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – GENETIC TESTING

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: GLOBAL GENETIC TESTING MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4: GLOBAL GENETIC TESTING MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5: GLOBAL PRENATAL AND NEWBORN TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL PRENATAL AND NEWBORN TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL DIAGNOSTIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL DIAGNOSTIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL PREDICTIVE & PRESYMPTOMATIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL PREDICTIVE & PRESYMPTOMATIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL CARRIER TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL CARRIER TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL PHARMACOGENOMIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL PHARMACOGENOMIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL OTHER TYPE GENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL OTHER TYPE GENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL MOLECULAR TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL MOLECULAR TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL CYTOGENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL CYTOGENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL BIOCHEMICAL TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL BIOCHEMICAL TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL GENETIC TESTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL GENETIC TESTING MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL GENETIC DISEASES DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL GENETIC DISEASES DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL CANCER DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL CANCER DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL CARDIOVASCULAR DISEASES DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL CARDIOVASCULAR DISEASES DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL GENETIC TESTING MARKET, BY DISEASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL GENETIC TESTING MARKET, BY DISEASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL CANCER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL CANCER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: GLOBAL HUNTINGTON’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42: GLOBAL HUNTINGTON’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43: GLOBAL SICKLE CELL ANEMIA MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44: GLOBAL SICKLE CELL ANEMIA MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45: GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46: GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47: GLOBAL ALZHEIMER’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48: GLOBAL ALZHEIMER’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49: GLOBAL RARE DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 50: GLOBAL RARE DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 51: GLOBAL THALASSEMIA MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52: GLOBAL THALASSEMIA MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53: GLOBAL OTHER DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 54: GLOBAL OTHER DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 55: GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 56: GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 57: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58: NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59: LEADING PLAYERS OPERATING IN NORTH AMERICA GENETIC TESTING MARKET

TABLE 60: EUROPE GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61: EUROPE GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62: LEADING PLAYERS OPERATING IN EUROPE GENETIC TESTING MARKET

TABLE 63: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 64: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 65: LEADING PLAYERS OPERATING IN ASIA-PACIFIC GENETIC TESTING MARKET

TABLE 66: REST OF WORLD GENETIC TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 67: REST OF WORLD GENETIC TESTING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 68: LEADING PLAYERS OPERATING IN REST OF WORLD GENETIC TESTING MARKET

TABLE 69: LIST OF MERGERS & ACQUISITIONS

TABLE 70: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 71: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 72: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

FIGURE 7: GLOBAL GENETIC TESTING MARKET, BY PRENATAL AND NEWBORN TESTING GENETIC TESTING, 2022-2030 (IN $ MILLION)

FIGURE 8: GLOBAL GENETIC TESTING MARKET, BY DIAGNOSTIC TESTING, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL CARRIER TESTING MARKET, BY CARRIER TESTING, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL GENETIC TESTING MARKET, BY PHARMACOGENOMIC TESTING, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 12: GLOBAL GENETIC TESTING MARKET, BY MOLECULAR TESTING, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL GENETIC TESTING MARKET, BY CYTOGENETIC TESTING, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL GENETIC TESTING MARKET, BY BIOCHEMICAL TESTING, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

FIGURE 16: GLOBAL GENETIC TESTING MARKET, BY GENETIC DISEASES DIAGNOSIS, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL GENETIC TESTING MARKET, BY CANCER DIAGNOSIS, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL GENETIC TESTING MARKET, BY CARDIOVASCULAR DISEASES DIAGNOSIS, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL GENETIC TESTING MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL GENETIC TESTING MARKET, GROWTH POTENTIAL, BY DISEASE, IN 2021

FIGURE 21: GLOBAL GENETIC TESTING MARKET, BY CANCER TESTING, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL GENETIC TESTING MARKET, BY CYSTIC FIBROSIS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL GENETIC TESTING MARKET, BY HUNTINGTON’S DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL GENETIC TESTING MARKET, SICKLE CELL ANEMIA, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL GENETIC TESTING MARKET, BY DUCHENNE MUSCULAR DYSTROPHY, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL GENETIC TESTING MARKET, BY ALZHEIMER’S DISEASE TESTING, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL GENETIC TESTING MARKET, BY RARE DISEASES TESTING, 2022-2030 (IN $ MILLION)

FIGURE 28: GLOBAL GENETIC TESTING MARKET, BY THALASSEMIA TESTING, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL GENETIC TESTING MARKET, BY OTHER DISEASES TESTING, 2022-2030 (IN $ MILLION)

FIGURE 30: NORTH AMERICA GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 31: UNITED STATES GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: CANADA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: EUROPE GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 33: UNITED KINGDOM GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: GERMANY GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: SPAIN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: ITALY GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: RUSSIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: NORDIC COUNTRIES GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: REST OF EUROPE GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 41: CHINA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: JAPAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: INDIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: SOUTH KOREA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: INDONESIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: AUSTRALIA & NEW ZEALAND GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: SINGAPORE GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: TAIWAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: REST OF ASIA-PACIFIC GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: REST OF WORLD GENETIC TESTING MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 49: LATIN AMERICA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: MIDDLE EAST & AFRICA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY TYPE
    • PRENATAL AND NEWBORN TESTING
    • DIAGNOSTIC TESTING
    • PREDICTIVE & PRESYMPTOMATIC TESTING
    • CARRIER TESTING
    • PHARMACOGENOMIC TESTING
    • OTHER TYPES
  2. MARKET BY TECHNOLOGY
    • MOLECULAR TESTING
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
  3. MARKET BY APPLICATION
    • GENETIC DISEASE DIAGNOSIS
    • CANCER DIAGNOSIS
    • CARDIOVASCULAR DISEASE DIAGNOSIS
    • OTHER APPLICATIONS
  4. MARKET BY DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • HUNTINGTON’S DISEASE
    • SICKLE CELL ANAEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • ALZHEIMER’S DISEASE
    • RARE DISEASES
    • THALASSEMIA
    • OTHER DISEASES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • SPAIN
        • ITALY
        • RUSSIA
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATE
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • AUSTRALIA & NEW ZEALAND
        • SINGAPORE
        • TAIWAN
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions & Answers (FAQs):

    What is the value of the global genetic testing market?

    As of 2021, the global genetic testing market was valued at $11.5 billion.

    Does this report include COVID-19 impact?

    Yes, the market study has also analyzed the impact of COVID-19 on the genetic testing market qualitatively as well as quantitatively.

    Which is the fastest-growing application in the global genetic testing market?

    Cardiovascular diseases diagnosis is the fastest-growing application in the global genetic testing market.

    Which is the largest revenue-generating application in the global genetic testing market?

    Genetic diseases diagnosis is the largest revenue-generating application in the global genetic testing market.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now